Question 1

What is PrimeC?

Accepted Answer

PrimeC is a Other.

Question 2

How often does PrimeC appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was PrimeC first tracked by Ergen?

Accepted Answer

First tracked on Jul 01, 2026.

Question 4

When was PrimeC last mentioned in news?

Accepted Answer

Last active on Jul 01, 2026.

Question 5

What is PrimeC's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is PrimeC in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving PrimeC?

Accepted Answer

NeuroDex ExoSORT ALS Biomarker Breakthrough (Jul 01, 2026, 6 articles).

Question 8

How did the "NeuroDex ExoSORT ALS Biomarker Breakthrough" event impact PrimeC?

Accepted Answer

PrimeC, NeuroSense Therapeutics' lead drug candidate, showed a statistically significant reduction in NDE-associated TDP-43 in the PARADIGM trial, indicating its potential as an effective treatment for ALS.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.